Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2025-12-29 @ 5:22 PM
Study NCT ID:
NCT04329403
Status:
WITHDRAWN
Last Update Posted:
2020-06-26
First Post:
2020-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%
Sponsor:
Aurobindo Pharma Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-05
Completion Date Type:
ESTIMATED
First Submit Date:
2020-03-30
First Submit QC Date:
None
Study First Post Date:
2020-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-24
Last Update Post Date:
2020-06-26
Last Update Post Date Type:
ACTUAL